Clinical Trial Update: Phase I STEBVax in Healthy Adults [Phase 1]

View source ↗

Summary

Phase I trial update for STEBVax in healthy adults; the study has completed to evaluate a vaccine against Staphylococcal enterotoxin B for toxic shock syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Staphylococcal Toxic Shock Syndrome

Drugs mentioned

• STEBVax

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Toxic Shock Syndrome Staphylococcal | Phase 1 | Status: COMPLETED